We recommend to use Procyon fundamental analysis to find out if markets are presently mispricing the firm. Put it differently this technique allows you to confirm available drivers of Procyon as well as the relationship between them. We have analyzed and interpolated thirty-three available financial ratios for Procyon, which can be compared to its competitors. The stock experiences a normal downward fluctuation but is a risky buy. Check odds of Procyon to be traded at $0.1881 in 90 days.
Procyon
Procyon Stock Summary
Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems in the United States. The company was incorporated in 1987 and is based in Oldsmar, Florida. Procyon Corp operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 19 people.
Procyon's financial ratios allow both analysts and investors to convert raw data from Procyon's financial statements into concise, actionable information that can be used to evaluate the performance of Procyon over time and compare it to other companies across industries.
Comparative valuation techniques use various fundamental indicators to help in determining Procyon's current stock value. Our valuation model uses many indicators to compare Procyon value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Procyon competition to find correlations between indicators driving Procyon's intrinsic value. More Info.
Procyon is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Procyon by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Procyon's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.
Procyon February 17, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Procyon help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Procyon. We use our internally-developed statistical techniques to arrive at the intrinsic value of Procyon based on widely used predictive technical indicators. In general, we focus on analyzing Procyon Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Procyon's daily price indicators and compare them against related drivers.
Other Information on Investing in Procyon Pink Sheet
Procyon financial ratios help investors to determine whether Procyon Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Procyon with respect to the benefits of owning Procyon security.